68 results
NT 10-K
PRPH
ProPhase Labs Inc
18 Mar 24
Notice of late annual filing
4:00pm
the assessment of the Company’s internal controls over financial reporting as of December 31, 2023.
The Company expects to file the Form 10-K
8-K
EX-10.1
PRPH
ProPhase Labs Inc
20 Dec 22
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
8:30am
deficiency, assessment, or adjustment has been proposed or assessed by any Governmental Entity against the Sellers, and the Sellers have not executed … any waiver of any statute of limitations on the assessment or collection of any Tax or agreed to any extension of time with respect to a Tax
8-K
EX-99.1
8ac8gry svzgohb
8 Nov 22
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
8:05am
8-K
EX-10.1
q6m6qo3bd1t
29 Dec 21
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
7i3xk531o8q5c ykrl55
16 Aug 21
ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
4:49pm
8-K
EX-10.1
iew2 2h9pnrlyc3v
26 Oct 20
ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing
4:15pm